Skip to main content
Clinical Cardiology logoLink to Clinical Cardiology
. 2009 Feb 3;21(9):649–653. doi: 10.1002/clc.4960210908

Maximizing the hemodynamic benefit of enhanced external counterpulsation

Krishnamurthy Suresh 1, Susan Simandl 1, Wiliiam E Lawson 1,, JOHN CK Hui 1, Oneida Lillis 1, Lynn Burger 1, Tong Guo 1, Peter F Cohn 1
PMCID: PMC6655932  PMID: 9755381

Abstract

Background: Enhanced external counterpulsation (EECP) has been demonstrated to be an effective treatment for angina and exertional ischemia in patients with coronary disease.

Hypothesis: It is hypothesized that the ability of EECP to enhance the recruitment or development of coronary collaterals in coronary artery disease may be determined by the relative magnitude of diastolic augmentation (DA) and systolic unloading (SU). This study examines the relation between the proposed EECP effectiveness ratio (DA/SU), as assessed by finger plethysmography, and changes in descending aortic flow as assessed by Doppler echocardiography in 15 patients during EECP.

Methods: Varying external cuff pressures (0‐275 mmHg) were used to generate a range of DA/SU ratios. The effect on aortic antegrade systolic and retrograde diastolic flow was assessed by Doppler echocardiography to determine whether there was an optimal EECP effectiveness ratio that maximizes the hemodynamic effects of EECP. With increasing DA/SU there was an initial positive linear increase in both systolic and diastolic flow volume. Systolic flow maximized at an effectiveness ratio of 1.5 and diastolic flow at a ratio of 2.0.

Result: Therefore, effectiveness ratios (DA/SU) in the range of 1.5‐2.0 are optimal for maximizing the hemodynamic effects of EECP.

Keywords: counterpulsation, diastolic augmentation, systolic unloading, hemodynamics, echocardiography

Full Text

The Full Text of this article is available as a PDF (707.2 KB).

References

  • 1. Lawson WE, Hui JCK, Soroff HS, Zheng ZS, Kayden DS, Sasvary D, Atkins H, Cohn PF: Efficacy of enhanced external counterpulsation in the treatment of angina pectoris. Am J Cardiol 1992; 70: 859–862 [DOI] [PubMed] [Google Scholar]
  • 2. Lawson WE, Hui JCK, Zheng ZS, Burger L, Jiang L, Lillis O, Oster Z, Soroff H, Cohn PF: Improved exercise tolerance following enhanced external counterpulsation: Cardiac or peripheral effect? Cardiology 1996; 87: 1–5 [DOI] [PubMed] [Google Scholar]
  • 3. Lawson WE, Hui JCK, Zheng ZS, Oster Z, Katz JP, Diggs P, Burger L, Cohn CD, Soroff HS, Cohn PF: Three‐year sustained benefit from enhanced external counterpulsation in chronic angina pectoris. Am J Cardiol 1995; 75: 840–841 [DOI] [PubMed] [Google Scholar]
  • 4. Lawson WE, Hui J, Burger L, Cohn PF: Five year follow‐up of morbidity and mortality in 33 angina patients treated with enhanced external counterpulsation. J Invest Med 1997; 45: 212A [Google Scholar]
  • 5. Lawson WE, Hui JCK, Zheng ZS, Burger L, Jiang L, Lillis O, Soroff HS, Cohn PF: Can angiographic findings predict which coronary patients will benefit from enhanced external counterpulsation? Am J Cardiol 1996; 77: 1107–1109 [DOI] [PubMed] [Google Scholar]
  • 6. Kern MJ, Aguirre FV, Tatineni S, Penick D, Serota H, Donohue T, Salter K: Enhanced coronary blood flow velocity during intra‐aortic balloon counterpulsation in critically ill patients. J Am Coll Cardiol 1993; 21: 359–368 [DOI] [PubMed] [Google Scholar]
  • 7. Kern MJ, Aguirre F, Bach R, Conohue T, Siegel R, Segal J: Augmentation of coronary blood flow by intra‐aortic blood flow by intra‐aortic balloon pumping in patients after coronary angioplasty. Circulation 1993; 87: 500–511 [DOI] [PubMed] [Google Scholar]
  • 8. Suresh K, Simandl S, Lawson WE, Hui JCK, Guo T, Burger L, Soroff H, Cohn PF: Acute hemodynamic benefit of enhanced external counterpulsation. J Am Coll Cardiol 1996; 27: 22A [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Clinical Cardiology are provided here courtesy of Wiley

RESOURCES